The DOI matches its Crossref record; 220 of the 227 references it cites were found in a registry or an index.
Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
Open accessAbstract
Elevated protein synthesis is an important feature of many cancer cells and often arises as a consequence of increased signaling flux channeled to eukaryotic initiation factor 4F (eIF4F), the key regulator of the mRNA–ribosome recruitment phase of translation initiation. In many cellular and preclinical models of cancer, eIF4F deregulation results in changes in translational efficiency of specific mRNA classes. Importantly, many of these mRNAs code for proteins that potently regulate critical cellular processes, such as cell growth and proliferation, enhanced cell survival and cell migration that ultimately impinge on several hallmarks of cancer, including increased angiogenesis, deregulated growth control, enhanced cellular survival, epithelial-to-mesenchymal transition, invasion, and metastasis. By being positioned as the molecular nexus downstream of key oncogenic signaling pathways (e.g., Ras, PI3K/AKT/TOR, and MYC), eIF4F serves as a direct link between important steps in cancer development and translation initiation. Identification of mRNAs particularly responsive to elevated eIF4F activity that typifies tumorigenesis underscores the critical role of eIF4F in cancer and raises the exciting possibility of developing new-in-class small molecules targeting translation initiation as antineoplastic agents. Cancer Res; 75(2); 250–63. ©2014 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Many direct eIF4A/eIF4F mRNA targets have been identified and often encode proteins that drive proliferation, metastasis, and survival (11, 14, 15).”
From Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer (2023) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Pardo, O. E., Arcaro, A., Salerno, G., Raguz, S., Downward, J., & Seckl, M. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.a115.109006 · Cited by 153
RetractedPardo, O. E., Arcaro, A., Salerno, G., Raguz, S., Downward, J., & Seckl, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109006200 · Cited by 145
RetractedThe landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Molecular mechanisms of mTOR-mediated translational control
Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558
eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,103
Self-citationA unifying model for mTORC1-mediated regulation of mRNA translation
Thoreen, C. C., Chantranupong, L., Keys, H. R., Wang, T., Gray, N. S., & Sabatini, D. M. (2012) · Nature · doi:10.1038/nature11083 · Cited by 1,477
Regulation of 4E-BP1 phosphorylation: a novel two-step mechanismPreprint
Gingras, A., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R. H., & Sonenberg, N. (1999) · Genes & Development · doi:10.1101/gad.13.11.1422 · Cited by 1,348
Self-citationThe translational landscape of mTOR signalling steers cancer initiation and metastasis
Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., et al. (2012) · Nature · doi:10.1038/nature10912 · Cited by 1,313
Self-citationPhosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268
Cited by
Sorted by citations
ERK signalling: A master regulator of cell behaviour, life and fate
Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
Chio, I. I. C., Jafarnejad, S. M., Ponz-Sarvise, M., Park, Y., Rivera, K., Palm, W., Wilson, J., Sangar, V., Hao, Y., Öhlund, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.056 · Cited by 378
“Of the four phases of protein synthesis (initiation, elongation, termination, and recycling), initiation is considered to be the rate-limiting step in mRNA translation and is often exploited by cancer cells to support tumorigenesis (Pelletier et al., 2015).”
InfluentialSelf-citationGenome editing of upstream open reading frames enables translational control in plants
Zhang, H., Si, X., Ji, X., Fan, R., Liu, J., Chen, K., Wang, D., & Gao, C. (2018) · Nature Biotechnology · doi:10.1038/nbt.4202 · Cited by 373
Translation from unconventional 5′ start sites drives tumour initiation
Sendoel, A., Dunn, J. G., Rodriguez, E. H., Naik, S., Gomez, N. C., Hurwitz, B. S., Levorse, J. M., Dill, B. D., Schramek, D., Molina, H., et al. (2017) · Nature · doi:10.1038/nature21036 · Cited by 339
Kern, L., Mittenbühler, M., Vesting, A., Ostermann, A., Wunderlich, C., & Wunderlich, F. (2018) · Cancers · doi:10.3390/cancers11010024 · Cited by 331
The SARS-CoV-2 RNA–protein interactome in infected human cells
Schmidt, N., Lareau, C. A., Keshishian, H., Ganskih, S., Schneider, C., Hennig, T., Melanson, R., Werner, S., Wei, Y., Zimmer, M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00846-z · Cited by 319
Cytoplasmic stress granules: Dynamic modulators of cell signaling and disease
Mahboubi, H., & Stochaj, U. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.12.022 · Cited by 282
Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma
Cerezo, M., Guemiri, R., Druillennec, S., Girault, I., Malka-Mahieu, H., Shen, S., Allard, D., Martineau, S., Welsch, C., Agoussi, S., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0217-1 · Cited by 257
Self-citationPadrón, A., Iwasaki, S., & Ingolia, N. T. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.030 · Cited by 257
Alternative approaches to target Myc for cancer treatment
Wang, C., Zhang, J., Yin, J., Gan, Y., Xu, S., Gu, Y., & Huang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00500-y · Cited by 251
Proteome complexity and the forces that drive proteome imbalance
Harper, J. W., & Bennett, E. J. (2016) · Nature · doi:10.1038/nature19947 · Cited by 239
Exploring the Impact of Single-Nucleotide Polymorphisms on Translation
Robert, F., & Pelletier, J. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00507 · Cited by 244
Self-citationSiddiqui, N., & Sonenberg, N. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150126 · Cited by 225
Self-citationHeterogeneity and specialized functions of translation machinery: from genes to organisms
Genuth, N. R., & Barna, M. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0008-z · Cited by 235
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Ahmadi, S. E., Rahimi, S., Zarandi, B., Chegeni, R., & Safa, M. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01111-4 · Cited by 223
Gandin, V., Masvidal, L., Hulea, L., Gravel, S., Cargnello, M., McLaughlan, S., Cai, Y., Balanathan, P., Morita, M., Rajakumar, A., et al. (2016) · Genome Research · doi:10.1101/gr.197566.115 · Cited by 204
Self-citationPausing on Polyribosomes: Make Way for Elongation in Translational Control
Richter, J. D., & Coller, J. (2015) · Cell · doi:10.1016/j.cell.2015.09.041 · Cited by 207
Müller, C., Schulte, F. W., Lange‐Grünweller, K., Obermann, W., Madhugiri, R., Pleschka, S., Ziebuhr, J., Hartmann, R. K., & Grünweller, A. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.12.010 · Cited by 204
Cancer the‘RBP’eutics–RNA-binding proteins as therapeutic targets for cancer
Mohibi, S., Chen, X., & Zhang, J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.07.001 · Cited by 207
Reich, S., Sprengeler, P. A., Chiang, G. G., Appleman, J. R., Chen, J. W., Clarine, J., Eam, B., Ernst, J. T., Han, Q., Goel, V., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01795 · Cited by 188
Merrick, W. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.675280 · Cited by 176
How Ribosomes Translate Cancer
Sulima, S. O., Hofman, I. J., Keersmaecker, K. D., & Dinman, J. D. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0550 · Cited by 184
Aptamers: Uptake mechanisms and intracellular applications
Yoon, S., & Rossi, J. J. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.003 · Cited by 171
Onset of differentiation is post-transcriptionally controlled in adult neural stem cells
Baser, A., Skabkin, M. A., Kleber, S., Dang, Y., Balta, G. S. G., Kalamakis, G., Göpferich, M., Ibañez, D. C., Schefzik, R., Lopez, A. S., et al. (2019) · Nature · doi:10.1038/s41586-019-0888-x · Cited by 169
Ernst, J. T., Thompson, P. A., Nilewski, C., Sprengeler, P. A., Sperry, S., Packard, G., Michels, T., Xiang, A., Tran, C., Wegerski, C. J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00182 · Cited by 150
Tailor made: the art of therapeutic mRNA design
Metkar, M., Pepin, C. S., & Moore, M. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00827-x · Cited by 158
Translation initiation by cap‐dependent ribosome recruitment: Recent insights and open questions
Shirokikh, N. E., & Preiß, T. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1473 · Cited by 142
Abbas, Y. M., Laudenbach, B. T., Martínez‐Montero, S., Cencic, R., Habjan, M., Pichlmair, A., Damha, M. J., Pelletier, J., & Nagar, B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612444114 · Cited by 140
Self-citationTranslation Initiation Factors: Reprogramming Protein Synthesis in Cancer
Chu, J., Cargnello, M., Topisirović, I., & Pelletier, J. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.06.005 · Cited by 135
Self-citationThe oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation
Sun, L.-Y., Wang, W., Han, C., Huang, W., Sun, Y., Fang, K., Zeng, Z., Yang, Q., Pan, Q., Chen, T., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.033 · Cited by 126
Guzzi, N., Muthukumar, S., Cieśla, M., Todisco, G., Ngoc, P. C. T., Madej, M., Munita, R., Fazio, S., Ekström, S., Blanco, T. M., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00852-9 · Cited by 124
Quan, Z., Yang, Y., Zheng, H., Zhan, Y., Luo, J., Ning, Y., & Fan, S. (2022) · Journal of Cancer · doi:10.7150/jca.77619 · Cited by 129
Sorafenib, a multikinase inhibitor, induces formation of stress granules in hepatocarcinoma cells
Adjibade, P., St-Sauveur, V. G., Huberdeau, M. Q., Fournier, M., Savard, A., Coudert, L., Khandjian, É. W., & Mazrouï, R. (2015) · Oncotarget · doi:10.18632/oncotarget.5980 · Cited by 114
eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma
Chan, K., Robert, F., Oertlin, C., Kapeller-Libermann, D., Avizonis, D., Gutierrez, J., Handly-Santana, A., Doubrovin, M., Park, J., Schoepfer, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13086-5 · Cited by 106
Self-citationEukaryotic translation initiation factors as promising targets in cancer therapy
Hao, P., Yu, J., Ward, R. J., Liu, Y., Qiao, H., An, S., & Xu, T. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00607-9 · Cited by 127
Wanted DEAD/H or Alive: Helicases Winding Up in Cancers
Cai, W., Chen, Z. X., Rane, G., Singh, S. S., Choo, Z., Wang, C., Yuan, Y., Tan, T. Z., Arfuso, F., Yap, C. T., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw278 · Cited by 116
Translation acrobatics: how cancer cells exploit alternate modes of translational initiation
Sriram, A., Bohlen, J., & Teleman, A. A. (2018) · EMBO Reports · doi:10.15252/embr.201845947 · Cited by 110
Molecular Pathways: The eIF4F Translation Initiation Complex—New Opportunities for Cancer Treatment
Malka-Mahieu, H., Newman, M., Désaubry, L., Robert, C., & Vagner, S. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2362 · Cited by 105
Translational control of aberrant stress responses as a hallmark of cancer
El-Naggar, A. M., & Sorensen, P. H. B. (2018) · The Journal of Pathology · doi:10.1002/path.5030 · Cited by 105
The natural compound silvestrol is a potent inhibitor of Ebola virus replication
Biedenkopf, N., Lange‐Grünweller, K., Schulte, F. W., Weißer, A., Müller, C., Becker, D., Becker, S., Hartmann, R. K., & Grünweller, A. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.011 · Cited by 102
Ma, X., Li, B., Liu, J., Fu, Y., & Luo, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1053-y · Cited by 97
Stress granule: A promising target for cancer treatment
Gao, X., Jiang, L., Gong, Y., Chen, X., Ying, M., Zhu, H., He, Q., Yang, B., & Cao, J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14790 · Cited by 93
Chen, H.-H., Yu, H.-I., Yang, M., & Tarn, W. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0282 · Cited by 90
Targeting RNA helicases in cancer: The translation trap
van Voss, M. R. H., van Diest, P. J., & Raman, V. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.09.006 · Cited by 90
Combinatorial Control of mRNA Fates by RNA-Binding Proteins and Non-Coding RNAs
Iadevaia, V., & Gerber, A. P. (2015) · Biomolecules · doi:10.3390/biom5042207 · Cited by 83
Xu, Z., Tian, P., Guo, J., Mi, C., Liang, T., Xie, J., Huang, W., Dai, M., Chen, W., & Zhang, H. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.145950 · Cited by 76
Tahmasebi, S., Jafarnejad, S. M., Tam, I. S., Gonatopoulos-Pournatzis, T., Matta‐Camacho, E., Tsukumo, Y., Yanagiya, A., Li, W., Atlasi, Y., Caron, M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615540113 · Cited by 76
Self-citationCatalysis-Based Total Syntheses of Pateamine A and DMDA-Pat A
Zhuo, C., & Fürstner, A. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b05094 · Cited by 75
Control of the eIF4E activity: structural insights and pharmacological implications
Romagnoli, A., D’Agostino, M., Ardiccioni, C., Maracci, C., Motta, S., Teana, A. L., & Marino, D. D. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03938-z · Cited by 74
mTOR-sensitive translation: Cleared fog reveals more trees
Masvidal, L., Hulea, L., Furic, L., Topisirović, I., & Larsson, O. S. (2017) · RNA Biology · doi:10.1080/15476286.2017.1290041 · Cited by 69
eIF4E-Dependent Translational Control: A Central Mechanism for Regulation of Pain Plasticity
Uttam, S., Wong, C., Price, T. J., & Khoutorsky, A. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00470 · Cited by 79
Mlakar, V., Morel, E., Mlakar, S. J., Ansari, M., & Gumy‐Pause, F. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01967-x · Cited by 72
PABPC1——mRNA stability, protein translation and tumorigenesis
Qi, Y., Wang, M., & Jiang, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1025291 · Cited by 72
Vaklavas, C., Blume, S. W., & Grizzle, W. E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00158 · Cited by 71
Stress granules: functions and mechanisms in cancer
Zhou, H., Luo, J., Mou, K., Peng, L., Li, X., Lei, Y., Wang, J., Lin, S., Luo, Y., & Li, X. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01030-6 · Cited by 72
Inhibition of Zika Virus Replication by Silvestrol
Elgner, F., Sabino, C., Basic, M., Ploen, D., Grünweller, A., & Hildt, E. (2018) · Viruses · doi:10.3390/v10040149 · Cited by 73
The 4E-BP–eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes
So, L., Lee, J., Palafox, M., Mallya, S., Woxland, C. G., Arguello, M., Truitt, M., Sonenberg, N., Ruggero, D., & Fruman, D. A. (2016) · Science Signaling · doi:10.1126/scisignal.aad8463 · Cited by 72
Self-citationEukaryotic translation initiation factors and cancer
Ali, M. U., Rahman, M. S. U., Jia, Z., & Jiang, C. (2017) · Tumor Biology · doi:10.1177/1010428317709805 · Cited by 70
Yeomans, A., Thirdborough, S. M., Valle‐Argos, B., Linley, A. J., Krysov, S. V., Sánchéz‐Hidalgo, M., Leonard, E., Ishfaq, M., Wagner, S. D., Willis, A. E., et al. (2015) · Blood · doi:10.1182/blood-2015-07-660969 · Cited by 69
RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer
Mehta, M., Raguraman, R., Ramesh, R., & Munshi, A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114569 · Cited by 69
Could the eIF2α-Independent Translation Be the Achilles Heel of Cancer?
Holčı́k, M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00264 · Cited by 68
Yang, H., Chennamaneni, L. R., Ho, M. W. T., Ang, S. H., Tan, E. S. W., Jeyaraj, D. A., Yeap, Y. S., Liu, B., Ong, E. H., Joy, J. K., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01714 · Cited by 65
Chen, Z., Qi, J.-J., Wu, Q., Lu, J., Liu, Z., Wang, Y., Hu, P., Li, T., Lin, J., Wu, X., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1178-z · Cited by 64
Hippuristanol - A potent steroid inhibitor of eukaryotic initiation factor 4A
Cencic, R., & Pelletier, J. (2016) · Translation · doi:10.1080/21690731.2015.1137381 · Cited by 63
Self-citationGeneral and Target-Specific DExD/H RNA Helicases in Eukaryotic Translation Initiation
Shen, L. L., & Pelletier, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124402 · Cited by 63
Self-citationTranslational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence
Raza, F., Waldron, J. A., & Quesne, J. L. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150163 · Cited by 61
Oncogene-dependent sloppiness in mRNA translation
Champagne, J., Pataskar, A., Blommaert, N., Nagel, R., Wernaart, D., Ramalho, S., Kenski, J. C. N., Bleijerveld, O. B., Zaal, E. A., Berkers, C. R., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.09.002 · Cited by 64
Tiu, G. C., Kerr, C. H., Forester, C. M., Krishnarao, P. S., Rosenblatt, H. D., Raj, N., Lantz, T. C., Zhulyn, O., Bowen, M. E., Shokat, L., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.06.013 · Cited by 59
Self-citationHuang, Y., Zhen, Y., Chen, Y., Sui, S., & Zhang, L. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115842 · Cited by 59
MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer
Zhao, Y., Yan, M., Ye, Y., Zhang, J., Zhang, R., Li, Y., Wu, X., Liu, Q., Miao, W., & Jiang, H. (2017) · Oncology Reports · doi:10.3892/or.2017.5502 · Cited by 58
Role of stress granules in tumorigenesis and cancer therapy
Li, T., Zeng, Z., Fan, C., & Xiong, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189006 · Cited by 56
Waldron, J. A., Tack, D. C., Ritchey, L. E., Gillen, S. L., Wilczynska, A., Turro, E., Bevilacqua, P. C., Assmann, S. M., Bushell, M., & Quesne, J. P. C. L. (2019) · Genome biology · doi:10.1186/s13059-019-1901-2 · Cited by 53
Geter, P. A., Ernlund, A. W., Bakogianni, S., Alard, A., Arju, R., Giashuddin, S. M., Gadi, A., Bromberg, J., & Schneider, R. J. (2017) · Genes & Development · doi:10.1101/gad.305631.117 · Cited by 56
Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers
Xue, C., Gu, X., Li, G., Bao, Z., & Li, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.711965 · Cited by 54
Anderson, G. R., Wardell, S. E., Cakir, M., Crawford, L., Leeds, J. C., Nussbaum, D. P., Shankar, P. S., Soderquist, R. S., Stein, E. M., Tingley, J. P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aae0348 · Cited by 53
Mechanisms Underlying Muscle Protein Imbalance Induced by Alcohol
Kimball, S. R., & Lang, C. H. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064642 · Cited by 54
Kumar, K., Chow, C. R., Ebine, K., Arslan, A. D., Kwok, B., Bentrem, D. J., Eckerdt, F., Platanias, L. C., & Munshi, H. G. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0285 · Cited by 52
Carter, J. H., Deddens, J. A., Spaulding, N. R., Lucas, D., Colligan, B. M., Lewis, T. G., Hawkins, E., Jones, J., Pemberton, J. O., Douglass, L. E., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2015.450 · Cited by 50
Self-citationAssembly of eIF3 Mediated by Mutually Dependent Subunit Insertion
Smith, M. D., de Tacca, L. A., Nitido, A. D., Montabana, E. A., Park, A., & Cate, J. H. D. (2016) · Structure · doi:10.1016/j.str.2016.02.024 · Cited by 54
Iaconis, D., Monti, M., Renda, M., van Koppen, A., Tammaro, R., Chiaravalli, M., Cozzolino, F., Pignata, P., Crina, C., Pucci, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01156-x · Cited by 55
Silvestrol Inhibits Chikungunya Virus Replication
Henß, L., Scholz, T., Grünweller, A., & Schnierle, B. S. (2018) · Viruses · doi:10.3390/v10110592 · Cited by 52
Dysregulation of mRNA translation and energy metabolism in cancer
Leibovitch, M., & Topisirović, I. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.11.001 · Cited by 46
Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness
Sridharan, S., Robeson, M., Tukaramrao, D. B., Howard, C. M., Subramaniyan, B., Tilley, A. M. C., Tiwari, A. K., & Raman, D. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01311 · Cited by 49
eIF4AII is dispensable for miRNA-mediated gene silencing
Galicia-Vázquez, G., Chu, J., & Pelletier, J. (2015) · RNA · doi:10.1261/rna.052225.115 · Cited by 47
Self-citationInhibiting 4EBP1 in Glioblastoma
Fan, Q. W., Nicolaides, T. P., & Weiss, W. A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0042 · Cited by 45
LRRK2 regulates retrograde synaptic compensation at the Drosophila neuromuscular junction
Penney, J., Tsurudome, K., Liao, E. H., Kauwe, G., Gray, L. A., Yanagiya, A., Calderon, M. R., Sonenberg, N., & Haghighi, A. P. (2016) · Nature Communications · doi:10.1038/ncomms12188 · Cited by 48
Self-citationJaiswal, P. K., Koul, S., Palanisamy, N., & Koul, H. K. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0947-2 · Cited by 46
Translational Regulation of Cancer Metastasis
Micalizzi, D. S., Ebright, R. Y., Haber, D. A., & Maheswaran, S. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2720 · Cited by 47
Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression
Gao, Z., Yuan, T., Zhou, X., Ni, P., Sun, G., Li, P., Cheng, Z., & Wang, X. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1423923 · Cited by 46
The TLK1-Nek1 axis promotes prostate cancer progression
Singh, V., Jaiswal, P. K., Ghosh, I., Koul, H. K., Yu, X., & Benedetti, A. D. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.041 · Cited by 46
Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers
Lock, R., Ingraham, R., Maertens, O., Miller, A. L., Weledji, N., Legius, E., Konicek, B. W., Yan, S.-C. B., Graff, J. R., & Cichowski, K. M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85183 · Cited by 45
Self-citationMechanistic/mammalian target of rapamycin: Recent pathological aspects and inhibitors
Abdel‐Maksoud, M. S., El–Gamal, M. I., Benhalilou, D. R., Ashraf, S., Mohammed, S. A., & Oh, C. (2018) · Medicinal Research Reviews · doi:10.1002/med.21535 · Cited by 45
Follo, C., Vidoni, C., Morani, F., Ferraresi, A., Seca, C., & Isidoro, C. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0354-2 · Cited by 45
Kong, T., Xue, Y., Cencic, R., Zhu, X., Monast, A., Fu, Z., Pilon, V., Sangwan, V., Guiot, M., Foulkes, W. D., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0162 · Cited by 46
Self-citationZhao, Y., Wang, Y., Chen, W., Bai, S., Wang, P., Zheng, M., Yang, Y., Cheng, B., & Luan, Z. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02390-0 · Cited by 45
RNA-binding proteins in cancer drug discovery
Bertoldo, J. B., Müller, S., & Hüttelmaier, S. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103580 · Cited by 49
Pharmacological eEF2K activation promotes cell death and inhibits cancer progression
Gassart, A. D., Demaria, O., Panès, R., Zaffalon, L., Ryazanov, A. G., Gilliet, M. F., & Martinon, F. (2016) · EMBO Reports · doi:10.15252/embr.201642194 · Cited by 44
Beyond molecular tumor heterogeneity: protein synthesis takes control
y Cajal, S. R., Castellví, J., Hümmer, S., Peg, V., Pelletier, J., & Sonenberg, N. (2018) · Oncogene · doi:10.1038/s41388-018-0152-0 · Cited by 44
Self-citationThe pathogenesis of mesothelioma is driven by a dysregulated translatome
Grosso, S., Marini, A., Gyurászová, K., Voorde, J. V., Sfakianos, A., Garland, G. D., Rubio, A., Mordue, R., Chernova, T., Morone, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25173-7 · Cited by 44
Key contribution of eIF4H-mediated translational control in tumor promotion
Vaysse, C., Philippe, C., Martineau, Y., Quelen, C., Hiéblot, C., Renaud, C., Nicaise, Y., Desquesnes, A., Pannese, M., Filleron, T., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5442 · Cited by 43
Metadata
- Authors
- Pelletier, J., Graff, J., Ruggero, D., & Sonenberg, N.
- Affiliations
- Institut du cancer Rosalind & Morris Goodman (CA)
- Eli Lilly (United States) (US)
- University of California, San Francisco (US)
- Corresponding author
- Pelletier, Jerry
- Venue
- Cancer Research
- Published
- 2015-01-14
- Volume
- 75
- Issue
- 2
- Pages
- 250-263
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC4299928
- OpenAlex
- W2005176113
- Cited by
- 367
- References
- 227
- Citations by year
- 2026: 18 · 2025: 18 · 2024: 30 · 2023: 36 · 2022: 30 · 2021: 39 · 2020: 32 · 2019: 35 · 2018: 40 · 2017: 33 · 2016: 37 · 2015: 19
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- U.S. Public Health Service (MOP-106530, MOP-115126)
- National Cancer Institute (R01CA140456, R01CA184624, R01CA154916)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Keywords
- eIF4F, translation initiation, cancer, translational regulation, oncogenic signaling, Ras, c-Myc, metastasis, epithelial-mesenchymal transition, angiogenesis, cell proliferation
- MeSH terms
- Animals, Antineoplastic Agents, Humans, Neoplasms, Eukaryotic Initiation Factor-4F, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
